ATAI Stock Price, Chart, Stats & News
Atai Beckley Inc. (ATAI) is a dividend-paying stock with a current dividend yield of 91.84% as of Sep 11, 2026. It pays $6.75 per share over the trailing twelve months and distributes annually.
ATAI chart
Fundamentals
Gross margin | 75.25% |
Operating margin | -2862.83% |
Pretax margin | -16137.86% |
Net margin | -16142.02% |
Effective tax rate | -0.05% |
ROA | -212.55% |
ROE | -389.74% |
D/E | 0.01x |
Interest coverage ratio | -100.57x |
ATAI valuation
P/E | – |
P/S | 154.54x |
P/B | 4.75x |
P/CF | -10.19x |
P/FCF | -5.53x |
P/OCF | -10.19x |
PEG | 0.01x |
EV multiple | -6.33x |
About
Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds: BPL-003: An intranasally administered formulation of mebufotenin benzoate salt, currently undergoing Phase 2a and 2b clinical trials for its potential in treating both treatment-resistant depression (TRD) and alcohol use disorder.
Related lists
Similar securities
Based on sector and market capitalization
